Ken Griffin Stereotaxis, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 6,100 shares of STXS stock, worth $12,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,100
Previous 5,900
3.39%
Holding current value
$12,139
Previous $10,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding STXS
# of Institutions
87Shares Held
41.5MCall Options Held
86.5KPut Options Held
43.2K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$27.2 Million8.6% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.83MShares$7.62 Million6.2% of portfolio
-
Redmile Group, LLC San Francisco, CA3.31MShares$6.58 Million0.34% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.76MShares$5.48 Million11.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.61MShares$5.2 Million0.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $149M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...